BrainStorm Cell Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to BrainStorm Cell Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update

Brainstorm Cell Therapeutics (BCLI) Tops Q3 EPS by 5c; Reports Cash and Cash Equivalents of $28M

November 15, 2021 7:13 AM EST

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q3 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

... More